Pretransplant Erythropoiesis Stimulating Agent Hyporesponsiveness is Associated with Increased Kidney Allograft Failure and Mortality

Abstract

Poor response to erythropoiesis stimulating agents (ESA) is associated with morbidity and mortality among dialysis patients. It is unclear whether the risk associated with poor ESA response during dialysis extends beyond kidney transplantation. We examined pretransplant ESA response and its effect on allograft failure and mortality